Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8401-8410 of 13158

Page
per page
  1. Z-YVAD-FMK
    A8955 Z-YVAD-FMK
     21 Citation
    Target: Caspases
    Summary: Caspase-1 inhibitor
      ≥31.55 mg/mL
  2. UMI-77
    B4881 UMI-77
     1 Citation
    Target: Mcl-1
    Summary: Mcl-1 inhibitor, novel
      ≥23.4 mg/mL
  3. A 366
    B4947 A 366
    Summary: G9a/GLP histone lysine methyltransferase inhibitor
  4. Darunavir Ethanolate
    B4950 Darunavir Ethanolate
    Summary: nonpeptidic HIV protease inhibitor
      ≥59.17 mg/mL
  5. Mesoridazine
    A8702 Mesoridazine
    Summary: A dopaminergic antagonist
      insoluble in H2O; ≥16.35 mg/mL
  6. GSK2801
    B5998 GSK2801
    Summary: inhibitor of BAZ2A and BAZ2B bromodomains
      insoluble in H2O; ≥18.55 mg/mL
  7. Fenofibric acid
    B6128 Fenofibric acid
    Summary: ppar inhibitor， lipid-lowering agent
      ≥31.9 mg/mL
  8. Pamapimod (R-1503, Ro4402257)
    B6188 Pamapimod (R-1503, Ro4402257)
    Summary: p38 MAPK inhibitor
      Soluble in DMSO
  9. AMG 337
    B6193 AMG 337
    Summary: MET inhibitor
      ≥46.3 mg/mL
  10. AG-221 (Enasidenib)
    B7804 AG-221 (Enasidenib)
     1 Citation
    Summary: mutant isocitrate dehydrogenase 2 (IDH2) inhibitor
      ≥47.3 mg/mL

Items 8401-8410 of 13158

Page
per page